CRITERIA FOR TERMINATION OF PHASE-II CHEMOTHERAPY FOR PATIENTS WITH PROGRESSIVE OR RECURRENT BRAIN-TUMOR

被引：10

作者：

FRIEDMAN, HS

SCHOLD, SC

DJANG, WT

KURTZBERG, J

LONGEE, DC

HALPERIN, EC

FALLETTA, JM

COLEMAN, RE

OAKES, WJ

机构：

[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710

[2] DUKE UNIV,MED CTR,DEPT RADIOL,DURHAM,NC 27710

来源：

关键词：

D O I：

10.1212/WNL.39.1.62

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：62 / 66

页数：5

共 6 条

[1]

DICHIRO G, 1987, AM J NEURORADIOL, V8, P1083

[2]

DICHIRO G, 1988, INVEST RADIOL, V5, P360

DOYLE, WK ;

BUDINGER, TF ;

VALK, PE ;

LEVIN, VA ;

GUTIN, PH .

[4] THE CHEMOTHERAPY OF POSTERIOR-FOSSA TUMORS IN CHILDHOOD [J].

FRIEDMAN, HS ;

OAKES, WJ .

[5] CHEMOTHERAPY OF PRIMARY BRAIN-TUMORS [J].

LEVIN, VA .

[6]

WITTES RE, 1985, CANCER TREAT REP, V69, P1235